Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 6 | 2022 | 1128 | 1.020 |
Why?
|
| Insulin Resistance | 1 | 2022 | 406 | 0.620 |
Why?
|
| Spirituality | 2 | 2005 | 47 | 0.460 |
Why?
|
| Weight Gain | 2 | 2022 | 163 | 0.440 |
Why?
|
| Hospital Design and Construction | 1 | 2013 | 2 | 0.420 |
Why?
|
| Medical Order Entry Systems | 1 | 2012 | 45 | 0.400 |
Why?
|
| Medication Errors | 1 | 2012 | 116 | 0.380 |
Why?
|
| Norovirus | 1 | 2011 | 6 | 0.380 |
Why?
|
| Virus Shedding | 1 | 2011 | 17 | 0.380 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 220 | 0.370 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 39 | 0.370 |
Why?
|
| Diarrhea | 1 | 2011 | 73 | 0.360 |
Why?
|
| Patient Participation | 1 | 2013 | 212 | 0.360 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 248 | 0.350 |
Why?
|
| Neoplasms | 3 | 2005 | 1258 | 0.350 |
Why?
|
| Patient Care Team | 1 | 2012 | 333 | 0.340 |
Why?
|
| Protestantism | 2 | 2005 | 4 | 0.290 |
Why?
|
| Catholicism | 2 | 2005 | 4 | 0.290 |
Why?
|
| Therapeutic Touch | 1 | 2007 | 2 | 0.290 |
Why?
|
| Stereotaxic Techniques | 1 | 2007 | 29 | 0.290 |
Why?
|
| Pain Management | 1 | 2007 | 148 | 0.250 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2004 | 29 | 0.230 |
Why?
|
| Pastoral Care | 1 | 2004 | 2 | 0.230 |
Why?
|
| Carcinoma, Lobular | 1 | 2004 | 23 | 0.230 |
Why?
|
| Neoplasms, Second Primary | 1 | 2004 | 41 | 0.230 |
Why?
|
| Pain | 1 | 2007 | 406 | 0.230 |
Why?
|
| Carcinoma in Situ | 1 | 2004 | 33 | 0.230 |
Why?
|
| Hospices | 1 | 2004 | 33 | 0.230 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2004 | 47 | 0.220 |
Why?
|
| Hospice Care | 1 | 2004 | 61 | 0.220 |
Why?
|
| Body Mass Index | 2 | 2022 | 889 | 0.200 |
Why?
|
| Nausea | 1 | 2003 | 109 | 0.200 |
Why?
|
| Vomiting | 1 | 2003 | 134 | 0.190 |
Why?
|
| Attitude to Health | 1 | 2004 | 279 | 0.190 |
Why?
|
| Antineoplastic Agents | 2 | 2007 | 647 | 0.190 |
Why?
|
| Female | 11 | 2022 | 31093 | 0.190 |
Why?
|
| Length of Stay | 1 | 2004 | 771 | 0.180 |
Why?
|
| Regression Analysis | 3 | 2007 | 486 | 0.170 |
Why?
|
| Massachusetts | 3 | 2013 | 2111 | 0.170 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2012 | 77 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 709 | 0.150 |
Why?
|
| Insulin | 1 | 2022 | 689 | 0.150 |
Why?
|
| Humans | 13 | 2022 | 59799 | 0.140 |
Why?
|
| Middle Aged | 7 | 2011 | 16397 | 0.130 |
Why?
|
| Prospective Studies | 1 | 2022 | 3110 | 0.120 |
Why?
|
| Physician Incentive Plans | 1 | 2013 | 9 | 0.110 |
Why?
|
| Multivariate Analysis | 2 | 2007 | 925 | 0.110 |
Why?
|
| Medical Oncology | 1 | 2013 | 57 | 0.110 |
Why?
|
| Hematologic Neoplasms | 1 | 2013 | 45 | 0.110 |
Why?
|
| Organizational Case Studies | 1 | 2013 | 45 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2007 | 405 | 0.100 |
Why?
|
| Anxiety | 2 | 2007 | 398 | 0.100 |
Why?
|
| Sex Factors | 2 | 2005 | 968 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2011 | 114 | 0.090 |
Why?
|
| Interviews as Topic | 1 | 2012 | 494 | 0.090 |
Why?
|
| Adult | 5 | 2007 | 15879 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 303 | 0.080 |
Why?
|
| Adolescent | 3 | 2005 | 5939 | 0.080 |
Why?
|
| Quality of Health Care | 1 | 2013 | 524 | 0.080 |
Why?
|
| Surveys and Questionnaires | 2 | 2007 | 2601 | 0.070 |
Why?
|
| Single-Blind Method | 1 | 2007 | 132 | 0.070 |
Why?
|
| Male | 5 | 2011 | 27765 | 0.070 |
Why?
|
| Aged | 4 | 2005 | 13461 | 0.060 |
Why?
|
| Biopsy | 1 | 2007 | 375 | 0.060 |
Why?
|
| Pain Measurement | 1 | 2007 | 335 | 0.060 |
Why?
|
| Risk Factors | 2 | 2007 | 5037 | 0.060 |
Why?
|
| Love | 1 | 2005 | 3 | 0.060 |
Why?
|
| Breast | 1 | 2007 | 173 | 0.060 |
Why?
|
| Fear | 1 | 2005 | 66 | 0.060 |
Why?
|
| Morale | 1 | 2004 | 4 | 0.060 |
Why?
|
| Religion and Psychology | 1 | 2004 | 15 | 0.060 |
Why?
|
| Anger | 1 | 2004 | 23 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2005 | 140 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2004 | 197 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 1231 | 0.050 |
Why?
|
| Emotions | 1 | 2005 | 217 | 0.050 |
Why?
|
| Feedback | 1 | 2003 | 87 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2004 | 455 | 0.050 |
Why?
|
| Health Services Research | 1 | 2004 | 270 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2004 | 672 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2005 | 413 | 0.050 |
Why?
|
| Mastectomy | 1 | 2022 | 54 | 0.050 |
Why?
|
| Mastectomy, Segmental | 1 | 2022 | 45 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2004 | 487 | 0.050 |
Why?
|
| Communication | 1 | 2005 | 556 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2003 | 372 | 0.040 |
Why?
|
| Logistic Models | 1 | 2004 | 1252 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 302 | 0.040 |
Why?
|
| Mammography | 1 | 2022 | 273 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2007 | 5204 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2005 | 556 | 0.040 |
Why?
|
| Obesity | 1 | 2007 | 1187 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2004 | 2461 | 0.040 |
Why?
|
| Time Factors | 1 | 2004 | 3589 | 0.030 |
Why?
|
| Reimbursement, Incentive | 1 | 2013 | 28 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2004 | 6041 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2013 | 331 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2013 | 426 | 0.020 |
Why?
|
| Celecoxib | 1 | 2005 | 14 | 0.020 |
Why?
|
| Taxoids | 1 | 2005 | 26 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2005 | 169 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 233 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2005 | 70 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2005 | 123 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2005 | 344 | 0.010 |
Why?
|
| United States | 1 | 2013 | 7568 | 0.010 |
Why?
|